Skip to main content
Quest Diagnostics

Chromogranin A Testing

Test code(s) 31912, 31911

As of April 19, 2021, Quest uses a liquid chromatography-tandem mass spectrometry (LC/MS/MS)-based assay to measure chromogranin (Chromogranin A, LC/MS/MS; test code 31911). Previously, chromogranin A was measured using an enzyme-linked immunosorbent assay (ELISA).

Typically, chromogranin A levels are around 2.5 times higher with the LC/MS/MS assay—this relationship is captured by the following equation: ELISA result = 13.6 + 0.36 × LC/MS/MS result; correlation coefficient = 0.71.

Reference intervals with both methods are shown below:

A “rebaseline” test code is offered for side-by-side determination of chromogranin A levels with both the ELISA and LC/MS/MS assay until April 19, 2022: Chromogranin A, Rebaseline (test code 31912). 

Details on methods and performance of the chromogranin A by LC/MS/MS assay have been published.1

If you have further questions or concerns, please contact Quest Client Services (1.800.642.4657).

Reference

  1. Weber DM, Yang JY, Goldman SM, et al. Clin Chem. 2021; in press.

    2.  

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Document FAQS.266 Version: 0
Version 0 effective 08/31/2021 to present

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.